Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice-Reference-Cited by-同舟云学术

Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice

Published:2016-06-02 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Wang Qixue,Sun Lei,Yang Xiaoxiao,Ma Xingzhe,Li Qi,Chen Yuanli,Liu Ying,Zhang Di,Li Xiaoju,Xiang Rong,Wei Yuquan,Han Jihong,Duan Yajun

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep27295.pdf

Reference30 articles.

1. Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 75, 163–189 (2004).

2. Kaplan, D. H. et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95, 7556–7561 (1998).

3. Shankaran, V. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410, 1107–1111 (2001).

4. O’Sullivan, T. et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med. 209, 1869–1882 (2012).

5. Baranowski, M. Biological role of liver X receptors. J Physiol Pharmacol. 59 Suppl 7, 31–55 (2008).

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profile of mRNA expression in the myometrium after intrauterine Escherichia coli injections in pigs;Theriogenology;2024-10

2. Targeting Liver X Receptors in Cancer Drug Discovery;Receptors;2024-06-29

3. Activation of CTU2 expression by LXR promotes the development of hepatocellular carcinoma;Cell Biology and Toxicology;2024-04-17

4. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities;Frontiers in Cell and Developmental Biology;2024-03-14

5. CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway;Cell Biology and Toxicology;2024-02-06